(b)(4).
Further information from the reporter regarding event, and product details has been requested.
No additional information is available at this time.
The events of "hemorrhagic cyst", "pustullation", and "erythema" are physiological complications and analysis of the device generally does not assist allergan in determining a probable cause for these events.
Device labeling addresses the reported event(s) as follows: undesirable effects the patients must be informed that there are potential side effects associated with implantation of this product, which may occur immediately or may be delayed.
These include, but are not limited to: inflammatory reactions (redness, oedema, erythema, etc.
) which may be associated with itching and/or pain on pressure and/or paresthesia, occurring after the injection.
These reactions may last for a week.
In particular, it has to be noticed that injection in the mucous membrane may cause more oedema and bruising due to the specific physiology of these tissues.
Besides, a preventive anti-inflammatory treatment by a medical practitioner can be recommended.
|
Healthcare professional reported patient was injected with juvéderm® volbella¿ with lidocaine in "forehead, between eyebrows".
The next day, patient presented with erythema.
On day 2, patient experienced "pustullation".
On day 3 patient developed "hemorrhagic cyst".
Patient treated with hyaluronidase, cipro (ciprofloxacin) 750, gripin (paracetamol + caffeine), and topical antibiotic.
Symptoms are ongoing.
|